Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat

Neuroendocrinology
R H Alper

Abstract

Serotonin (5-HT) and 5-HT agonists act on multiple 5-HT receptor subtypes to increase corticosterone secretion. The present experiments describe the effects of a highly selective 5-HT2 receptor agonist DOI [(+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl] on plasma corticosterone in conscious, unrestrained, male rats with indwelling arterial and venous catheters. DOI (500 micrograms/kg, i.v.) increased plasma corticosterone levels 6- to 7-fold from 15 to 60 min. Pretreatment with the central 5-HT2 antagonist LY 53857 (100 micrograms/kg, i.v.) blocked the effect of DOI on corticosterone secretion at all times. The peripheral 5-HT2 antagonist xylamidine (100 micrograms/kg, i.v.) attenuated the corticosterone response elicited 15 min after DOI but did not alter the 60-min response. In contrast, dexamethasone pretreatment (350 micrograms/kg, s.c.) attenuated the corticosterone response to DOI at 15 min, but abolished the response at 60 min. The increase in corticosterone levels elicited 5 min after the nonselective 5-HT agonist quipazine (3 mg/kg, i.v.) was also reduced by xylamidine. These data suggest that 5-HT2 receptor agonists increase corticosterone secretion initially, in part, through a direct adrenal mechanism not e...Continue Reading

Citations

Aug 4, 2004·Psychopharmacology·Shigeo MiyataJunzo Kamei
Mar 17, 1992·European Journal of Pharmacology·V Baudrie, F Chaouloff
Oct 6, 1992·European Journal of Pharmacology·A D LevyL D Van de Kar
Jan 1, 1993·Life Sciences·J YamadaK Horisaka
Jun 1, 1993·Pharmacology, Biochemistry, and Behavior·A M Souquet, M Fantino
Jan 1, 1993·Brain Research. Brain Research Reviews·F Chaouloff
Apr 1, 1992·Brain Research Bulletin·S KawanoH Yamashita
Jun 1, 1992·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P BroquaF Chaouloff
Jan 11, 2001·Physiology & Behavior·P F Frohlich, C M Meston
Dec 14, 2002·Pharmacology, Biochemistry, and Behavior·D D SoaresU Marubayashi
Sep 24, 1999·Pharmacology, Biochemistry, and Behavior·L M SchrottS B Sparber
Dec 28, 2000·Behavioural Brain Research·L A Hanson, B B Gorzalka
Oct 4, 2007·Behavioural Pharmacology·Vincent J Aloyo, Kuldip D Dave
Mar 8, 2008·Critical Reviews in Toxicology·N Kreke, D R Dietrich
May 22, 2010·General and Comparative Endocrinology·Lea R MedeirosM Danielle McDonald
May 4, 2010·Cardiovascular Therapeutics·Stephanie W Watts, Robert Patrick Davis
Mar 28, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Emily R HawkenNicholas J Delva
Apr 16, 2005·Clinical Science·Stephanie W Watts
Mar 17, 2018·Frontiers in Pharmacology·Emmanuelle A D SchindlerDeepak C D'Souza
Jan 1, 1997·Medicine and Science in Sports and Exercise·J M Davis, S P Bailey
Nov 12, 2020·Journal of Psychopharmacology·Ari Brouwer, Robin Lester Carhart-Harris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.